Mark Andrew Frye
Chair, Department of Psychiatry and Psychology, Mayo Clinic (Rochester, Minnesota)
Key Impact
He is a leading mood-disorders psychiatrist whose work has helped shape the clinical evidence base and consensus guidance for ketamine in depression.
Background & Research
Mark Andrew Frye, M.D., is a psychiatrist at Mayo Clinic in Rochester, Minnesota, where he serves as Chair of Psychiatry and Psychology and as the inaugural Director of the Mayo Clinic Depression Center. His research focuses on mood disorders, bipolar disorder, biomarker development, and translational psychiatry, including ketamine and other novel treatments for depression.
Collaboration Network
8 collaborators· click a node to visit their profile
Full network →